Search Within

Gastrointestinal Oncology Service

  1. "2010"
Formats
  1. Journal Article (54)
  2. Meeting Abstract (38)
  3. Book Section (6)
  4. Book Whole (2)
Groups
  1. Department of Medicine (100)
  2. Solid Tumor Oncology Division (100)
  3. Center for Pancreatic Cancer Research (42)
  4. Surgery (31)
  5. Biostatistics Service (16)
  6. Department of Pathology and Laboratory Medicine (16)

More Groups

People
  1. Leonard Saltz (29)
  2. Nancy Kemeny (21)
  3. Eileen O'Reilly (15)
  4. Yelena Janjigian (15)
  5. David Kelsen (14)
  6. Manish Shah (14)

More People

Years
  1. 2010 (100)
Publications
  1. Journal of Clinical Oncology (39)
  2. Cancer (4)
  3. Journal of the National Comprehensive Cancer Network (4)
  4. International Journal of Radiation Oncology, Biology, Physics (3)
  5. Annals of Oncology (2)
  6. Annals of Surgical Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. Springer (12)
  3. Elsevier Inc. (8)
  4. Wiley Blackwell (8)
  5. Lippincott Williams & Wilkins (5)
  6. Harborside Press (4)

More Publishers

Results (100)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Non-surgical treatment of hepatocellular carcinoma
    Book Section

    Abou-Alfa, G. K.; Brown, K. T.
    In Poston, G. J.; D'Angelica, M.; Adam, R. (Eds.) Surgical Management of Hepatobiliary and Pancreatic Disorders. 2nd ed (2010)

    Fulltext@MSK | Save
  • Chemotherapy for metastatic colorectal cancer
    Book Section

    Power, D. G.; Kemeny, N. E.
    In Poston, G. J.; D'Angelica, M.; Adam, R. (Eds.) Surgical Management of Hepatobiliary and Pancreatic Disorders. 2nd ed (2010)

    Fulltext@MSK | Save
  • Treatment of liver metastases
    Book Section

    Kemeny, N. E.; D'Angelica, M.
    In Hong, W. K.; Bast, R. C. Jr; Hait, W. N.; Kufe, D. W.; Pollock, R. E.; Weichselbaum, R. R.; Holland, J. F.; Frei, E. 3rd (Eds.) Holland-Frei Cancer Medicine. 8th ed (2010)

    Fulltext@MSK | Save
  • Dynamic contrast enhanced MRI (DCE-MRI) to measure antiangiogenic therapy and predict treatment response in primary liver cancer (PLC)
    Meeting Abstract

    Yopp, A. C.; Schwartz, L. H.; Kemeny, N. E.; Gultekin, D.; Gonen, M.; Bamboat, Z.; Shia, J.; D'Angelica, M. I.; DeMatteo, R. P.; Jarnagin, W. R.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Vitamin D levels and survival in colorectal cancer (CRC)
    Meeting Abstract

    Wesa, K. M.; Jacobs, G.; Woo, D.; Cronin, A.; Segal, N. H.; Coleton, M.; Saltz, L.; Cassileth, B. R.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Association between smoking history and disease-free and overall survival in resected gastric cancer
    Meeting Abstract

    Smyth, E. C.; Strong, V. E.; Capanu, M.; Janjigian, Y. Y.; Coit, D. G.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Perioperative chemotherapy plus bevacizumab with early salvage therapy based on PET response in patients with locally advanced resectable gastric/GEJ cancer
    Meeting Abstract

    Smyth, E. C.; Schoder, H.; Coit, D. G.; Strong, V. E.; Brennan, M. F.; Janjigian, Y. Y.; Capanu, M.; Tang, L. H.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Random assignment multicenter phase II study of modified docetaxel, cisplatin, fluorouracil (mDCF) versus DCF with growth factor support (GCSF) in metastatic gastroesophageal adenocarcinoma (GE)
    Meeting Abstract

    Shah, M. A.; Shibata, S.; Stoller, R. G.; Kemeny, M.; Ritch, P. S.; Krishnamurthi, S. S.; Su, Y. B.; Janjigian, Y. Y.; Capanu, M.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060)
    Meeting Abstract

    Shah, M. A.; Smyth, E. C.; Shibata, S.; Yong, W.; Tang, L. H.; Janjigian, Y. Y.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Meeting Abstract

    Riely, G. J.; Janjigian, Y. Y.; Azzoli, C. G.; Pietanza, M.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Miller, V. A.; Pao, W.; Ginsberg, M. S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save